Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-07-26
1998-04-28
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514180, 514874, 514899, 514935, A61K 3156
Patent
active
057444641
ABSTRACT:
Antigestagens inhibit prostaglandin synthesis by the uterus and thus can be used to treat symptoms of dysmennhorea.
REFERENCES:
patent: 3077437 (1963-02-01), Heckel
patent: 3666858 (1972-05-01), Hughes et al.
patent: 4609651 (1986-09-01), Rohde et al.
patent: 4626531 (1986-12-01), Elger et al.
patent: 4780461 (1988-10-01), Neef et al.
patent: 4814327 (1989-03-01), Ottow et al.
patent: 4870069 (1989-09-01), Ottow et al.
7-8.
Pickles et al., J. Obstet. Gynecol. Br. Commonw., vol. 72,1965,pp. 185-192.
Willman et al., British Journal of Obstetrics and Gynaecology, vol. 83, No. 3, May 1976, pp. 337-341.
Maathuis et al., J. Endocr. (1978, 77, 361-371.
Elger et al., Am. J. Obstet. Gynecol., vol. 157 (4Pt2), 1987 Oct., pp. 1065-1074.
J. P. Wolf et al., "Progesterone antagonist (RU 486) for cervical . . . ", Am J Obstet Gynecol, Jan. 1989, pp. 45-47.
G. Haluska et al., "Temporal changes in uterine activity and . . . ", Am J Obstet Gynecol, Dec. 1987, pp. 1487-1495.
D.G. Porter, "The Failure of Porgesterone to Affect Myometrial . . . ", J. Endocr (1970), 46, 425-434.
Kettel et al., "Endocrine responses to long-term administration of . . . ", Gynecology-endocrinology, vol. 56, No. 3, Sep., 1991, pp. 402-407.
W. Elger, "Pharmacology of Parturition and Abortion", Anim Reprod Sci, 2 (1979) pp. 133-148.
W. Elger et al., "Studies on Labor-Conditioning and Labor-Inducing . . . ", Uterine Contractility, R. Garfield ed., Serono Symposia, USA, Uterine Contractility, R. Garfield ed., Serono Symposia, USA,.
W. Elger et al., "Studies on Interactions of Antiprogestins With . . . ", Hormone Antagonists for Fertility Regulation, C.P. Puri ed., pp. 105-121.
Shi Shai Qing et al., "PGFM and Sex Steroid Concentrations Throughout . . . ", Hormone Antagonists for Fertility Regulation, pp. 87-97.
W. Elger et al., "Studies on the Mechanism of Action of Antifertile . . . ", Acta Physiologica Hungarica, vol. 65(4), pp. 415-432 (1985).
W. Elger et al., "Endometrial and myometrail effects of progesterone . . . ", Am J Obstet Gynecol, vol. 157, No. 4, Oct. 1987, pp. 1065-1074.
R. Frydman et al., "Labor Induction in Women at Term With . . . ", Obstetrice & Gynecology, vol. 80, No. 6, pp. 972-975.
N.C.W. Hill et al., "Transplacental passage of mifepristone and its . . . ", Human Reproduction, vol. 6, No. 3, pp. 458-462, 1991.
L.M. Kettel et al., Society for Gynecologic Investigation Abstract, S136, "Lont-Term, Low-Dose RU 486 in the Treatment of Endometriosis".
The Merck Manual, Fifteenth Edition, pp. 1700-1713 (1987).
Baulieu et al, Human Reproduction, vol. 1, No. 2, pp. 107-110 (1986).
Beier Sybille
Chwalisz Krzysztof
Elger Walter
Fahnrich Marianne
Achutamurthy Ponnathapura
Schering Aktiengesellschaft
LandOfFree
Antigestagens for the inhibition of uterine synthesis of prostag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigestagens for the inhibition of uterine synthesis of prostag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigestagens for the inhibition of uterine synthesis of prostag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1532101